14-day Premium Trial Subscription Sign Up For FreeGet Free

BioPharmX Corporation Stock Forecast NYSE:BPMX

$0.41 (6.79%)

Volume: 1M

Closed: Dec 07, 2021

Hollow Logo Score: -4.262

BioPharmX Corporation Stock Forecast

$0.41 (6.79%)

Volume: 1M

Closed: Dec 07, 2021

Score Hollow Logo -4.262
Which way will BPMX go? Request
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 33 and the stock is currently not being overbought or oversold

Strong day for BioPharmX Corporation stock price on Tuesday rising 6.79% to $0.41
(Updated on Dec 07, 2021)

Sell candidate since 2021-11-02 Loss -49.28%

The BioPharmX Corporation stock price gained 6.79% on the last trading day (Tuesday, 7th Dec 2021), rising from $0.38 to $0.41. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 9.21% from a day low at $0.38 to a day high of $0.42. The price has fallen in 7 of the last 10 days and is down by -13.77% for this period. Volume fell on the last day by -638 thousand shares and in total, 1 million shares were bought and sold for approximately $558.70 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -50.34% during the next 3 months and, with a 90% probability hold a price between $0.18 and $0.29 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 8.21%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioPharmX Corporation stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.41 and $0.57. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss

BioPharmX Corporation finds support from accumulated volume at $0.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0350 between high and low, or 9.21%. For the last week the stock has had a daily average volatility of 10.85%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is BioPharmX Corporation stock A Buy?

BioPharmX Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.262

Predicted Opening Price for BioPharmX Corporation of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$0.40 $0.41 (Overvalued)
Sell Candidate Upgraded

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 10.85 %
Overall Risk: Very High High Medium Low Very Low
10.85 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $0.46
Price: $0.41
Support: $0.40

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.44 7.26 %
0.42 3.97 %
0.41 1.93 %
Current price: 0.41
Support 0.39 -4.66 %
0.38 -6.69 %
0.37 -9.99 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.50 24.20 %
0.47 15.97 %
0.46 13.38 %
Current price 0.41
Support 0.40 -1.80%
0.38 -6.36%
0.38 -7.59%

Click to get the best stock tips daily for free!

About BioPharmX Corporation

BioPharmX BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health and dermatology markets. The company offers prescription and over-the-counter (OTC) products in oral, topical, and injectable forms. It provides VI2OLET iodine, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and for the alleviation of symptoms of fibrocystic breast condition (... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE